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Abstract
Background: Tungsten carbide (WC) and tungsten carbide cobalt (WC-Co) nanoparticles are of occupational health
relevance because of the increasing usage in hard metal industries. Earlier studies showed an enhanced toxic
potential for WC-Co compared to WC or cobalt ions alone. Therefore, we investigated the impact of these particles,
compared to cobalt ions applied as CoCl2, on the global gene expression level in human keratinocytes (HaCaT) in
vitro.
Results: WC nanoparticles exerted very little effects on the transcriptomic level after 3 hours and 3 days of
exposure. In contrast, WC-Co nanoparticles caused significant transcriptional changes that were similar to those
provoked by CoCl2. However, CoCl2 exerted even more pronounced changes in the transcription patterns. Gene
set enrichment analyses revealed that the differentially expressed genes were related to hypoxia response,
carbohydrate metabolism, endocrine pathways, and targets of several transcription factors. The role of the
transcription factor HIF1 (hypoxia inducible factor 1) is particularly highlighted and aspects of downstream events
as well as the role of other transcription factors related to cobalt toxicity are considered.
Conclusions: This study provides extensive data useful for the understanding of nanoparticle and cobalt toxicity. It
shows that WC nanoparticles caused low transcriptional responses while WC-Co nanoparticles are able to exert
responses similar to that of free cobalt ions, particularly the induction of hypoxia-like effects via interactions with
HIF1a in human keratinocytes. However, the enhanced toxicity of WC-Co particles compared to CoCl2 could not
be explained by differences in gene transcription.
Background
Engineered nanomaterials are used in large amounts in
several industries and an increasing demand, including
new types of particles, is anticipated in the future [1].
Their physico-chemical properties, i.e. the small size and
the high surface to volume ratio are one of the most
interesting characteristics, which is useful for many appli-
cations in medicine, chemistry, material sciences and
physics. However, these physico-chemical characteristics
may be associated with undesired health effects not
known for, or different from, the bulk materials. Hence,
the field of nanotoxicology is emerging to assess possible
hazards of nanomaterials. Several reviews have sum-
marised the potential cellular mechanisms of
nanoparticles toxicity such as increase in the production
of reactive oxygen species (ROS) and induction of inflam-
matory responses [2-4]. The cellular responses appear to
be dependent on the physical and chemical properties of
the particles, such as particle size, dissolution behaviour,
surface reactivity and binding ability [2,5,6].
So far, the majority of in vivo and in vitro studies in
nanotoxicology have focussed on endpoints such as vital-
ity, production of reactive oxygen species, immunological
parameters or cell death. However, the elucidation of the
mode of action and identification of subacute effects with
potential implications for chronic toxicity are difficult to
obtain from these studies. Therefore, modern toxicoge-
nomic approaches established already in pharmacology
and toxicology [7-10] could be used to unravel the toxi-
codynamics of nanomaterials. First studies on the effects
of nano- or ultrafine particles on global gene expression
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responses due to the exposure to particles [11-14].
Hence, the chemical composition of the particles seems
to play a major role for transcriptional responses. Griffitt
and colleagues [11] showed that metal ions (silver and
copper) caused similar expression patterns as nanoparti-
cles of the same materials in zebrafish, but the numbers
of affected genes were always higher after exposure to
the particles. In an in vitro study by Waters et al. [12] it
was found that changes in cell viability provoked by silica
exhibited a higher correlation with particle surface area
than either particle mass or number in macrophages.
The majority of biological processes represented by the
differentially expressed genes were nearly identical, irre-
spective of particle diameter.
A toxicogenomic approach has been used in this study
to analyse the mode of action of tungsten carbide (WC)
and tungsten carbide cobalt (WC-Co) nanoparticles.
These nanoparticles are intended to be increasingly used
in hard metal industries for the production of wear
resistant and hard tools. The major advantage of using
WC and WC-Co nano-scaled instead of micro-scaled
particles is the increased hardness of resulting compo-
site materials and therefore a prolonged wear lifespan of
tools and other products [15]. Cobalt serves as binding
agent improving the sintering of hard metals from WC
nanoparticles. Therefore, the use of WC-Co particles is
favoured in hard metal industries. Potential health impli-
cations may be of concern for workers involved in the
manufacturing process. Previous studies using μm-sized
particles have indicated a lack of toxicity for WC parti-
cles but a hazardous potential for cobalt metal particles
in vivo and in vitro [16-18]. A mixture of these μm-
scaled powders (WC-Co) exhibited an enhanced toxicity
if compared to cobalt metal powder alone [16-20]. Our
previous research also showed toxicity enhancing effects
for nano-sized WC-Co compared to WC or CoCl2
[21,22]. The increased toxicity was proposed to result
from specific interactions of WC and cobalt. Since the
International Agency for Research on Cancer (IARC)
has classified cobalt as ‘possibly carcinogenic’ and tung-
sten carbide cobalt as ‘probably carcinogenic’ to humans
[23] research on the elucidation of the mode of action
of nano-sized particles of these materials is of high rele-
vance for occupational health. Ionic cobalt (Co
2+)i s
known to exert hypoxia like responses via stabilising the
a subunit of the hypoxia inducible transcription factor
(HIF1) [24-26]. Ubiquitously expressed HIF1a is
degraded via oxygen-dependent prolyl-4-hydroxylation
under normoxic conditions [27]. These degradation pro-
cesses are blocked by cobalt binding or oxygen defi-
ciency (hypoxia) which results in enriched HIF1a levels
in the cells. HIF1 is a transcription factor that mediates
response to hypoxia by regulating the transcription of
genes encoding proteins that play key roles in angiogen-
esis, glucose and energy metabolism, cell survival and
proliferation, iron metabolism, and vascular functions
[28,29]. Comparative gene expression studies showed
HIF1-mediated responses to be similar for hypoxia and
CoCl2 exposure [8,30].
Whether metallic cobalt in nanoparticles, particularly
in combination with tungsten, provokes specific toxic
effects deviating from or exceeding those observed for
dissolved ionic cobalt is not finally clarified yet. Lison
and co-workers [31] described the formation of reactive
oxygen species (ROS) after a rapid dissolution of cobalt
ions out of WC-Co micrometer sized particles in a cell
free system, a phenomenon that could not be found
with metal cobalt particles or a combination of WC par-
ticles with CoCl2. Furthermore, another study that eval-
uated the role of ROS in the interactive toxicity of
carbide-cobalt mixtures found no evidence that produc-
tion of ROS contributed to the toxicity of WC-Co in
macrophages [32]. Lombaert and co-workers [33] inves-
tigated gene expression in macrophages exposed to
micrometer sized WC-Co particles (a mixture of cobalt
metal with a median particle size (d50)o f4μm and WC
particles d50 <1μm). They identified differential expres-
sion of genes involved in apoptosis regulation, stress
response, glucose metabolism, cell signalling, immune
response and other pathways. The effects were discussed
to be at least partially provoked by dissolved cobalt ions.
In a previous study [21] we have investigated the
impact of WC and WC-Co nanoparticles on the vitality
of various mammalian cells (lung, skin, colon and oligo-
dendrocyte cell lines; primary neural cell and astroglial
cultures). Significant cytotoxic effects were observed for
nano-sized WC-Co (33 μg/ml). About 15% of WC and
76% of Co were found to be dissolved after 1 week of
storage of the stock solution. Interestingly, WC-Co par-
ticles (consisting of 30 μg/ml WC and 3 μg/ml cobalt)
showed a higher toxicity than equivalent concentrations
of CoCl2 (3 μg/ml) indicating that leaching of cobalt
alone may not explain the toxic effects. It was also
demonstrated that the tungsten based nanoparticles
could enter various cell types [21,22]. Based on this
study we selected the human skin cell line HaCaT to
investigate the effects of WC and WC-Co nanoparticles
and cobalt ions on gene expression patterns. Our major
goal was to elucidate (1) whether the observed effects
indicate specific mode of actions of WC-Co nanoparti-
cles and/or (2) whether the effects can primarily be
explained by dissolved Co.
Results
We compared the mode of action of WC and WC-Co
nanoparticles and dissolved CoCl2 in HaCaT cells by
recording changes in transcription profiles by microarray
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tration of WC-Co causing a reduction of cell vitality (33
μg/ml; [21]) and corresponding concentrations of WC
and CoCl2. RNA isolated after 3 h and 3 d of exposure
from 5 independent biological replicates per treatment
was analysed using a commercial human whole genome
microarray. Various analyses routines were performed to
identify differentially expressed genes, treatment clusters
and affected biological pathways.
Identification of differentially expressed genes
SAM analysis of normalised microarray fluorescence
intensities for all treatments revealed 1956 significantly
differentially expressed genes with about 1146 showing
an induction or repression of more than 2fold. The high-
est number of genes with a significantly altered expres-
sion above 2fold was observed after 3 d of exposure
(Table 1). Among the different treatments, exposure to
CoCl2 provoked the strongest changes in gene expression
(373 and 826 genes for 3 h and 3 d of exposure, respec-
tively) followed by WC-Co (37 and 248, respectively) and
WC nanoparticles (28 and 49 respectively). Comparison
of the genes affected by the different treatments revealed
a considerable overlap of transcription profiles. The high-
est commonalities were observed between the gene
expression patterns of CoCl2 and WC-Co after 3 d of
exposure (184 genes differentially expressed in both
treatments), followed by the exposure to CoCl2 at 3 h
and 3 d (134 genes) and WC/WC-Co at 3 d (31 genes). A
list of the genes with the strongest differential expression
(>5fold) can be found in Table 2, the complete set of
genes is available in the Additional file 1.
Confirmation of microarray data
In order to verify the microarray results, RT-PCR analysis
was conducted using the same set of samples used for the
microarrays as well as RNA samples from independent
exposure experiments. Twelve genes with significantly
differential expression and a minimum of 2fold up- or
downregulation were selected for RT-PCR confirmation.
However, care was taken that genes with weak (close to
2fold differential expression) and strong changes (up to
23fold) in expression were included (Figure 1). For eight
of the selected genes the significant changes of expres-
sion could be confirmed (BN I P 3 ,L O X L 2 ,A N G P T L 4 ,
CA9, PFKFB4, KRT1, MAL, MMP1). Trends (induction
or repression) were conserved between microarray and
RT-PCR data for each treatment. The remaining genes
(GAPDH, ID2, OLFM4, DSG4) exhibited a high variabil-
ity and could not be confirmed as statistically significant
from controls by RT-PCR.
PCA and cluster analyses
Two methods of descriptive statistics - PCA (principal
component analysis) and HCA (hierarchical cluster ana-
lysis) - were applied to identify commonalities or differ-
ences between treatments based on the patterns of
significantly differentially expressed genes. By PCA ana-
lysis about 65% of the variability in different treatments
was represented by the first 3 components. Four clearly
separated clusters, i.e. cells treated with CoCl2 for 3 h,
the same treatment for 3 d, cells treated with WC-Co
for 3 d and cells treated with WC for 3 d were identified
(Figure 2). All other treatments, including the controls,
were not separated and formed a large cluster with
apparently weak gene expression changes if compared to
controls. WC-treated cells were less clearly separated
from controls. This was indicated by the observation
that a clear distinct cluster was only demonstrated for
PC axis 2 and 3.
Similar results were obtained by HCA, which identi-
fied 3 treatment clusters. Both CoCl2 treatments and the
3 d exposures of WC-Co formed a distinct cluster. All
other treatments (controls, WC3d, WC3h, WC-Co3h)
were grouped in one cluster (Additional file 2). Gene
clustering revealed two clusters with strongly induced
genes. Genes of these clusters (i.e. LOXL2, BNIP3, CA9,
PDK1, ASB2, EGLN3, ANKRD37, PNCK) are coding for
proteins with diverse functions, but some of them are
Table 1 Number of significant repressed or induced genes > 2fold per treatment*.
Treatment up down total Treatment Overlapping genes between treatments
WC3h 26 2 28 WC3h WC3h
WCCo3h 13 24 37 WCCo3h 8 WCCo3h
CoCl3h 242 131 373 CoCl3h 8 17 CoCl3h
WC3d 18 31 49 WC3d 3 2 11 WC3d
WCCo3d 141 107 248 WCCo3d 2 8 29 31 WCCo3d
CoCl3d 541 285 826 CoCl3d 8 15 134 19 184
* identified with SAM; the pair wise comparison indicates genes that were differentially expressed in both of the considered treatments
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#.
WC
3h
WCCo
3h
CoCl2
3h
WC
3d
WCCo
3d
CoCl2
3d
Gene Name Accession Description
up up up up up PPFIA4 NM_015053 protein tyrosine phosphatase, receptor type, f polypeptide
(PTPRF), interacting protein (liprin), alpha 4 (PPFIA4), mRNA
[NM_015053]
up up up up BNIP3 NM_004052 BCL2/adenovirus E1B 19 kDa interacting protein 3 (BNIP3),
nuclear gene encoding mitochondrial protein, mRNA
[NM_004052]
up up up up PDK1 NM_002610 pyruvate dehydrogenase kinase, isozyme 1 (PDK1), nuclear
gene encoding mitochondrial protein, mRNA [NM_002610]
up up up CA9 NM_001216 carbonic anhydrase IX (CA9), mRNA [NM_001216]
up up up EGLN3 NM_022073 egl nine homolog 3 (C. elegans) (EGLN3), mRNA
[NM_022073]
up up up LOXL2 NM_002318 lysyl oxidase-like 2 (LOXL2), mRNA [NM_002318]
up up up THC2369600 THC2369600 ALU6_HUMAN (P39193) Alu subfamily SP sequence
contamination warning entry, partial (12%) [THC2369600]
up up PLOD2 NM_182943 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2),
transcript variant 1, mRNA [NM_182943]
up up PPP1R3C NM_005398 protein phosphatase 1, regulatory (inhibitor) subunit 3C
(PPP1R3C), mRNA [NM_005398]
up up CST6 NM_001323 cystatin E/M (CST6), mRNA [NM_001323]
up up FN1 NM_212482 fibronectin 1 (FN1), transcript variant 1, mRNA [NM_212482]
up up THC2316753 THC2316753 Q91TG6 (Q91TG6) T130, partial (7%) [THC2316753]
up up VLDLR NM_003383 very low density lipoprotein receptor (VLDLR), transcript
variant 1, mRNA [NM_003383]
up up AML1a ENST00000358356 mRNA for AML1a protein, complete cds. [D43967]
up up HK2 NM_000189 hexokinase 2 (HK2), mRNA [NM_000189]
up up PTGS2 NM_000963 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H
synthase and cyclooxygenase) (PTGS2), mRNA [NM_000963]
up up SLC2A14 BC060766 solute carrier family 2 (facilitated glucose transporter),
member 14, mRNA (cDNA clone MGC:71510
IMAGE:5297510), complete cds. [BC060766]
up up GPI NM_000175 glucose phosphate isomerase (GPI), mRNA [NM_000175]
up up ENO2 NM_001975 enolase 2 (gamma, neuronal) (ENO2), mRNA [NM_001975]
up up CDH2 NM_001792 cadherin 2, type 1, N-cadherin (neuronal) (CDH2), mRNA
[NM_001792]
up up AK021874 ENST00000366930 cDNA FLJ11812 fis, clone HEMBA1006364. [AK021874]
up up up up ASB2 NM_016150 ankyrin repeat and SOCS box-containing 2 (ASB2), mRNA
[NM_016150]
up up up up ANGPTL4 NM_139314 angiopoietin-like 4 (ANGPTL4), transcript variant 1, mRNA
[NM_139314]
up up up LOC653068 XM_925841 PREDICTED: similar to TBP-associated factor 9L (LOC653068),
mRNA [XM_925841]
up up TCF19 BC033086 transcription factor 19 (SC1), mRNA (cDNA clone
MGC:45652 IMAGE:3160434), complete cds. [BC033086]
up up AIPL1 NM_014336 aryl hydrocarbon receptor interacting protein-like 1 (AIPL1),
transcript variant 1, mRNA [NM_014336]
up up LOC200726 XM_117266 PREDICTED: hypothetical LOC200726 (LOC200726), mRNA
[XM_117266]
up up LUZPP1 AJ312775 mRNA for leucine zipper protein 3 (LUZP3 gene).
[AJ312775]
up C9orf65 NM_138818 chromosome 9 open reading frame 65 (C9orf65), mRNA
[NM_138818]
up THC2411387 THC2411387 ALU8_HUMAN (P39195) Alu subfamily SX sequence
contamination warning entry, partial (9%) [THC2411387]
up SOX6 NM_033326 SRY (sex determining region Y)-box 6 (SOX6), transcript
variant 2, mRNA [NM_033326]
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up SULT2A1 NM_003167 sulfotransferase family, cytosolic, 2A,
dehydroepiandrosterone (DHEA)-preferring, member 1
(SULT2A1), mRNA [NM_003167]
up C1orf67 BC042869 cDNA clone IMAGE:5270407. [BC042869]
up CRB1 NM_201253 crumbs homolog 1 (Drosophila) (CRB1), mRNA
[NM_201253]
up up EDN2 NM_001956 endothelin 2 (EDN2), mRNA [NM_001956]
up CBLN4 NM_080617 cerebellin 4 precursor (CBLN4), mRNA [NM_080617]
up G65686 ENST00000332107 A117 Human STS cDNA, sequence tagged site. [G65686]
up XAGE2 NM_130777 X antigen family, member 2 (XAGE2), mRNA [NM_130777]
up PELO AF118075 PRO1770 mRNA, complete cds. [AF118075]
up SAA3P AY209188 truncated serum amyloid A3 precursor (SAA3) mRNA,
complete cds. [AY209188]
up ITIH5 NM_030569 inter-alpha (globulin) inhibitor H5 (ITIH5), transcript variant
1, mRNA [NM_030569]
up MCHR1 NM_005297 melanin-concentrating hormone receptor 1 (MCHR1),
mRNA [NM_005297]
up MGAT4A NM_012214 mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-
acetylglucosaminyltransferase, isozyme A (MGAT4A), mRNA
[NM_012214]
up GPR65 NM_003608 G protein-coupled receptor 65 (GPR65), mRNA
[NM_003608]
up DFNB31 AK056190 cDNA FLJ31628 fis, clone NT2RI2003344, weakly similar to
PRESYNAPTIC PROTEIN SAP97. [AK056190]
up LRP8 NM_033300 low density lipoprotein receptor-related protein 8,
apolipoprotein e receptor (LRP8), transcript variant 2, mRNA
[NM_033300]
dn up up up SORCS3 NM_014978 sortilin-related VPS10 domain containing receptor 3
(SORCS3), mRNA [NM_014978]
dn up HLA-DPA1 NM_033554 major histocompatibility complex, class II, DP alpha 1 (HLA-
DPA1), mRNA [NM_033554]
up dn dn AKR1C1 BC040210 aldo-keto reductase family 1, member C1, mRNA (cDNA
clone MGC:42600 IMAGE:4825338), complete cds.
[BC040210]
up dn up WDR64 NM_144625 WD repeat domain 64 (WDR64), mRNA [NM_144625]
dn up ESCO2 NM_001017420 establishment of cohesion 1 homolog 2 (S. cerevisiae)
(ESCO2), mRNA [NM_001017420]
dn up CACNG5 NM_145811 calcium channel, voltage-dependent, gamma subunit 5
(CACNG5), transcript variant 1, mRNA [NM_145811]
dn up ANPEP NM_001150 alanyl (membrane) aminopeptidase (aminopeptidase N,
aminopeptidase M, microsomal aminopeptidase, CD13,
p150) (ANPEP), mRNA [NM_001150]
dn up GPX7 NM_015696 glutathione peroxidase 7 (GPX7), mRNA [NM_015696]
dn dn up TTLL7 NM_024686 tubulin tyrosine ligase-like family, member 7 (TTLL7), mRNA
[NM_024686]
dn dn up THC2371963 THC2371963 AIP1_HUMAN (Q86UL8) Atrophin-1 interacting protein 1
(Atrophin-1 interacting protein A) (MAGI-2), partial (3%)
[THC2371963]
up dn dn GDF15 NM_004864 growth differentiation factor 15 (GDF15), mRNA
[NM_004864]
dn dn ALDH1A1 NM_000689 aldehyde dehydrogenase 1 family, member A1 (ALDH1A1),
mRNA [NM_000689]
dn dn DCN NM_001920 decorin (DCN), transcript variant A1, mRNA [NM_001920]
dn dn SOX2 NM_003106 SRY (sex determining region Y)-box 2 (SOX2), mRNA
[NM_003106]
dn dn TAF9B NM_015975 TAF9B RNA polymerase II, TATA box binding protein (TBP)-
associated factor, 31 kDa (TAF9B), mRNA [NM_015975]
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dn dn THC2302184 THC2302184 GAL2_HUMAN (Q01415) N-acetylgalactosamine kinase
(GalNAc kinase) (Galactokinase 2), partial (21%)
[THC2302184]
dn dn PTPRZ1 NM_002851 protein tyrosine phosphatase, receptor-type, Z polypeptide
1 (PTPRZ1), mRNA [NM_002851]
dn dn DMRT2 NM_006557 doublesex and mab-3 related transcription factor 2
(DMRT2), transcript variant 1, mRNA [NM_006557]
dn dn CLEC3A NM_005752 C-type lectin domain family 3, member A (CLEC3A), mRNA
[NM_005752]
dn dn ATP10B AB018258 mRNA for KIAA0715 protein, partial cds. [AB018258]
dn dn PROS1 NM_000313 protein S (alpha) (PROS1), mRNA [NM_000313]
dn dn RAXLX NM_001008494 RAX-like homeobox (RAXLX), mRNA [NM_001008494]
dn dn OLFM4 NM_006418 olfactomedin 4 (OLFM4), mRNA [NM_006418]
dn dn DSG4 NM_177986 desmoglein 4 (DSG4), mRNA [NM_177986]
dn dn dn IQGAP2 NM_006633 IQ motif containing GTPase activating protein 2 (IQGAP2),
mRNA [NM_006633]
dn dn dn MAL NM_002371 mal, T-cell differentiation protein (MAL), transcript variant a,
mRNA [NM_002371]
dn dn dn KRT1 NM_006121 keratin 1 (epidermolytic hyperkeratosis) (KRT1), mRNA
[NM_006121]
dn dn dn MMP1 NM_002421 matrix metallopeptidase 1 (interstitial collagenase) (MMP1),
mRNA [NM_002421]
dn dn dn LAMP3 NM_014398 lysosomal-associated membrane protein 3 (LAMP3), mRNA
[NM_014398]
dn dn dn HLA-DMB NM_002118 major histocompatibility complex, class II, DM beta (HLA-
DMB), mRNA [NM_002118]
dn dn dn HERC5 NM_016323 hect domain and RLD 5 (HERC5), mRNA [NM_016323]
dn BTN3A3 NM_006994 butyrophilin, subfamily 3, member A3 (BTN3A3), transcript
variant 1, mRNA [NM_006994]
dn C6orf130 NM_145063 chromosome 6 open reading frame 130 (C6orf130), mRNA
[NM_145063]
dn CRY2 NM_021117 cryptochrome 2 (photolyase-like) (CRY2), mRNA
[NM_021117]
dn TMEM140 NM_018295 transmembrane protein 140 (TMEM140), mRNA
[NM_018295]
dn ZNF438 NM_182755 zinc finger protein 438 (ZNF438), mRNA [NM_182755]
dn DNMT3L NM_013369 DNA (cytosine-5-)-methyltransferase 3-like (DNMT3L),
transcript vari ant 1, mRNA [NM_013369]
dn CTAGE3 AF338231 CTAGE-3 protein mRNA, complete cds. [AF338231]
dn MOSPD2 NM_152581 motile sperm domain containing 2 (MOSPD2), mRNA
[NM_152581]
dn OR4N4 NM_001005241 olfactory receptor, family 4, subfamily N, member 4
(OR4N4), mRNA [NM_001005241]
dn SPATA7 NM_018418 spermatogenesis associated 7 (SPATA7), transcript variant 1,
mRNA [NM_018418]
dn TMC1 NM_138691 transmembrane channel-like 1 (TMC1), mRNA [NM_138691]
# listed genes were statistically significant different and exhibited at least a 5fold induction or repression in one of the treatments (with respect to controls and
based on normalised fluorescence intensity ratios in the microarray analysis); type of gene regulation is indicated as “up” for induction (> 2fold) and “dn” for
repression (> 2fold); fields are empty when induction or repression was < 2fold; full table is provided as Additional File 1
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Figure 1 Validation of microarray data by RT-PCR. Relative gene expression of arbitrarily selected genes in HaCaT cells after 3 d of exposure
to 30 μg/ml WC and 33 μg/ml WC-Co nanoparticles and 3 μg/ml CoCl2 was analysed by semiquantiative RT-PCR. Selected genes represent
genes with significant changes (2 to 23fold) of expression levels in microarrays. Gene expression values were converted to percent of the mean
of controls and are presented as mean + standard deviation (SD). Statistical differences were analysed with one-way ANOVA followed by
Dunnett’s post test (treatment vs. control). Values of p < 0.05 were considered statistically significant; *p < 0.05, **p < 0.01.
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HIF1a (see below). For the remaining clusters it was
not possible to identify predominating groups of gene
ontology. Therefore, gene clusters were not analysed in
detail but two types of pathway analysis were used to
identify signalling pathways and biological functions
associated with the differentially expressed genes.
Gene set enrichment analysis (GSEA) and identification of
affected signalling pathways
Pathway analysis was performed by two approaches,
with (1) GSEA software [34,35] using the complete set
of gene expression data from the microarray experi-
ments, and (2) the DAVID database [36] using the list
of more then 2fold differentially expressed genes pre-
viously identified with SAM.
GSEA identified communalities with existing gene sets
(enrichment) primarily for induced genes. The highest
number of affected gene sets was found for the 3 d
WC-Co treatment. The majority of pathways associated
with down-regulated gene sets were found after 3 h of
exposure with WC-Co. An overview of pathway related
gene sets with the highest commonality (based on statis-
tical significance analysis) to the observed patterns of
differentially expressed genes is given in Table 3.
Gene sets related to the hypoxia pathway as well as
carbohydrate metabolism were induced by WC-Co and
CoCl2 after 3 d. A significant association with the induc-
tion of the hypoxia gene sets was also observed after 3 h
of exposure with WC-Co. As indicated by the enrich-
ment of genes for the transcription factor HIF1a
(hypoxia inducible factor 1 alpha), regulation via HIF1a
may play a major role in provoking the observed
changes in hypoxia and carbohydrate metabolism genes.
Furthermore, GSEA detected an enrichment of genes
related to RNA metabolism and processing as well as
genes coding for proteins of the nucleus and the nuclear
membrane. These gene sets referred mainly to genes
down-regulated after 3 h of exposure to WC-Co nano-
particles. Some of the genes with strong differential
r e p r e s s i o n( >5 f o l d ;e . g .M AL, KRT1, GDF15, MMP1;
identified by SAM) were not found to be included in
these pathways.
DAVID revealed similar results as GSEA. However,
small gene sets, for instance a down-regulation of metal-
lothioneins in the 3 h CoCl2 exposure, were additionally
identified by DAVID. Furthermore, genes coding for
several proteins containing a functional prolyl-4-hydro-
xylase alpha subunit were highlighted as up-regulated
for the 3 d of exposure with CoCl2 and WC-Co.
The complete results of the GSEA and DAVID ana-
lyses are provided in the Additional file 3.
Discussion
The increasing use of nanoparticles may also lead to an
increased human exposure and adverse health effects.
Occupational exposure is one of the most relevant expo-
sure routes. In order to estimate the potential human
health impacts of nanoparticles a precise knowledge on
their mechanism of action is indispensable. This knowl-
edge allows, for instance, clarifying whether effects are
 
-60 
-40 
-20 
0 
20 
40 
60 
-60 
-40 
-20 
0 
20 
40 
60 
-60  -40  -20  0  20  40 60 80
Component 1 (41.5%) 
-60 -40 -20 0  20  40 60
Component 2 (15.1%) 
C
o
m
p
o
n
e
n
t
 
2
 
(
1
5
.
1
%
)
 
C
o
m
p
o
n
e
n
t
 
3
 
(
9
.
2
%
)
 
H2O 3h 
WC 3h 
WC-Co 3h 
CoCl2 3h 
 
H2O 3d 
WC 3d 
WC-Co 3d 
CoCl2 3d 
 
Figure 2 Principle component analyses. PCA of differentially expressed genes in HaCaT cells exposed for 3 h and 3 d to 30 μg/ml WC, 33 μg/
ml WC-Co nanoparticles and 3 μg/ml CoCl2. Each symbol represents a biological replicate.
Busch et al. BMC Genomics 2010, 11:65
http://www.biomedcentral.com/1471-2164/11/65
Page 8 of 21Table 3 Gene sets with strongest overlaps with observed differentially expressed genes.*
up-regulated gene sets description WC
3h
WCCo
3h
CoCl2
3h
WC
3d
WCCo
3d
CoCl2
3d
hypoxia related gene sets
HIF1_TARGETS Hif-1 (hypoxia-inducible
factor 1) transcriptional
targets
0.17 0.01
HIFPATHWAY BIOCARTA: Under normal
conditions, HIF-1 is
degraded; under hypoxic
conditions, it activates
transcription of genes
controlled by hypoxic
response elements (HREs)
0.02 0.20
HYPOXIA_FIBRO_UP Up-regulated by hypoxia in
normal fibroblasts from
both young and old
donors
0.20 0.65 0.05
HYPOXIA_NORMAL_UP Up-regulated by hypoxia in
normal, RPTEC renal cells
0.50 0.02
HYPOXIA_REG_UP Up-regulated by hypoxia in
renal cells, and down-
regulated with
reoxygenation
0.05 0.01 0.03
HYPOXIA_REVIEW Genes known to be
induced by hypoxia
0.22 0.75 0.00
MANALO_HYPOXIA_UP Genes up-regulated in
human pulmonary
endothelial cells under
hypoxic conditions or after
exposure to AdCA5, an
adenovirus carrying
constitutively active
hypoxia-inducible factor 1
(HIF-1alpha)
0.24 0.01 0.21
MENSE_HYPOXIA_UP List of Hypoxia-induced
genes found in both
Astrocytes and HeLa Cell
0.00 0.02 0.13
RESPONSE_TO_HYPOXIA GO:0001666. Change in
state or activity of a cell or
an organism (in terms of
movement, secretion,
enzyme production, gene
expression, etc.) as a result
of a stimulus indicating
lowered oxygen tension
0.12 0.08
carbohydrate metabolism
POLYSACCHARIDE_METABOLIC_PROCESS GO:0005976. Chemical
reactions and pathways
involving polysaccharides,
a polymer of more than 10
monosaccharide residues
joined by glycosidic
linkages
0.06
FRUCTOSE_AND_MANNOSE_METABOLISM Genes involved in fructose
and mannose metabolism
0.21 0.02
HSA00010_GLYCOLYSIS_AND_ GLUCONEOGENESIS KEGG: Genes involved in
glycolysis and
gluconeogenesis
0.00 0.14
GLYCOGEN_METABOLISM Genes involved in
glycogen metabolism
0.04
GALACTOSE_METABOLISM Genes involved in
galactose metabolism
0.04
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Page 9 of 21Table 3: Gene sets with strongest overlaps with observed differentially expressed genes.* (Continued)
PENTOSE_PHOSPHATE_PATHWAY Genes involved in pentose
phosphate pathway
0.61 0.14
STARCH_AND_SUCROSE_ METABOLISM Genes involved in starch
and sucrose metabolism
0.01 0.50
endocrine metabolism
GN_CAMP_GRANULOSA_UP Up-regulated in human
granulosa cells by the
gonadotropins LH and
FSH, as well as by cAMP-
stimulator forskolin
0.01 0.17
LH_GRANULOSA_UP Up-regulated in human
granulosa cells stimulated
with luteinizing hormone
(LH)
0.01
FSH_GRANULOSA_UP Up-regulated in human
granulosa cells stimulated
with follicle stimulation
hormone (FSH)
0.01
BREAST_CANCER_ESTROGEN_SIGNALING Genes preferentially
expressed in breast
cancers, especially those
involved in estrogen-
receptor- dependent signal
transduction
0.05
PROSTAGLANDIN_SYNTHESIS_ REGULATION WIKIPATHWAYS:
Prostaglandin Synthesis
and Regulation
0.09
HSA04150_MTOR_SIGNALING_ PATHWAY KEGG: Genes involved in
mTOR signalling pathway
0.19
cell adhesion, structure, cytoskeleton
HSA04510_FOCAL_ADHESION KEGG: Genes involved in
focal adhesion
0.07 0.46
ACTIN_CYTOSKELETON GO:0015629. Part of the
cytoskeleton (the internal
framework of a cell)
composed of actin and
associated proteins
0.04
ACTIN_BINDING GO:0003779. Interacting
selectively with monomeric
or multimeric forms of
actin, including actin
Filaments
0.06
CYTOSKELETON_DEPENDENT_ INTRACELLULAR_TRANSPORT GO:0030705. The directed
movement of substances
along cytoskeletal
elements such as
microfilaments or
microtubules within a cell
0.07
ANATOMICAL_STRUCTURE_FORMATION GO:0048646. Process
pertaining to the initial
formation of an anatomical
structure from unspecified
parts
0.04
VASCULATURE_DEVELOPMENT GO:0001944. Process
whose specific outcome is
the progression of the
vasculature over time, from
its formation to the mature
structure
0.04
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ANGIOGENESIS GO:0001525. Blood vessel
formation when new
vessels emerge from the
proliferation of pre-existing
blood vessels
0.05
HSA04512_ECM_ RECEPTOR_INTERACTION KEGG: Genes involved in
ECM-receptor interaction
0.06 0.29
miscellaneous
G13_SIGNALING_PATHWAY G13 signaling pathway 0.10 0.51
NUCLEOTIDE_BIOSYNTHETIC_PROCESS GO:0009165. Chemical
reactions and pathways
resulting in the formation
of nucleotides
0.09
CARBON_CARBON_LYASE_ACTIVITY GO:0016830. Catalysis of
the cleavage of C-C bonds
by other means than by
hydrolysis or oxidation, or
conversely adding a group
to a double bond
0.10
ALKPATHWAY Activin receptor-like kinase
3 (ALK3) is required during
gestation for cardiac
muscle development
0.29
CARDIACEGFPATHWAY BIOCARTA: Cardiac
hypertrophy, a response to
high blood pressure, is
stimulated by GPCR ligands
such as angiotensin II that
activate the EGF pathway
0.21 0.01
WNT_SIGNALING Wnt signaling genes 0.01
HSA05211_RENAL_CELL_CARCINOMA Genes involved in renal
cell carcinoma
0.07
NKTPATHWAY BIOCARTA: T cell
differentiation into Th1 and
Th2 cells occurs by
differential chemokine
receptor expression, which
mediates tissue localization
and immune response
0.29
BIOGENIC_AMINE_SYNTHESIS WIKIPATHWAYS: Genes
involved in synthesis of
biogenic amines
0.23
HSA00591_LINOLEIC_ACID_METABOLISM Genes involved in linoleic
acid metabolism
0.22
HSA00361_GAMMA_HEXACHLOROCYCLOHEXANE_DEGRADATION KEGG: Genes involved in
gamma-
hexachlorocyclohexane
degradation
0.17
down-regulated gene sets description WC
3h
WCCo
3h
CoCl2
3h
WC
3d
WCCo
3d
CoCl2
3d
RNA metabolism and processing
MRNA_METABOLIC_PROCESS GO:0016071. Chemical
reactions and pathways
involving mRNA
0.23
RIBONUCLEOPROTEIN_COMPLEX_ GO:0022613. The cellular
process by which a
complex containing RNA
and proteins, is
synthesized,
0.25
BIOGENESIS_AND_ASSEMBLY aggregates, and bonds
together
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Page 11 of 21Table 3: Gene sets with strongest overlaps with observed differentially expressed genes.* (Continued)
RNA_PROCESSING GO:0006396. Any process
involved in the conversion
of one or more primary
RNA transcripts into one or
more mature RNA
molecules
0.20
RNA_SPLICING__VIA_TRANSESTERIFICATION_ REACTIONS GO:0000375. Splicing of
RNA via a series of two
transesterification reactions
0.20
SEQUENCE_SPECIFIC_ DNA_BINDING GO:0043565. Interacting
selectively with DNA of a
specific nucleotide
composition, e.g. GC-rich
DNA binding, or with a
specific sequence motif or
type of DNA e.g. promotor
binding or rDNA binding
0.33
TRNA_METABOLIC_PROCESS GO:0006399. Chemical
reactions and pathways
involving tRNA
0.27
nucleus and the nuclear membrane related gene sets
PORE_COMPLEX GO:0046930. Any small
opening in a membrane
that allows the passage of
gases and/or liquids.
0.28
NUCLEAR_PORE GO:0005643. Any of the
numerous similar discrete
openings in the nuclear
envelope of a eukaryotic
cell, where the inner and
outer nuclear membranes
are joined
0.19
NUCLEAR_LUMEN GO:0031981. The volume
enclosed by the nuclear
inner membrane
0.31
NUCLEAR_MEMBRANE GO:0031965. Either of the
lipid bilayers that surround
the nucleus and form the
nuclear envelope; excludes
the intermembrane space
0.31
enzyme and receptor activity
UBIQUITIN_PROTEIN_ LIGASE_ACTIVITY GO:0004842. Catalysis of
the reaction: ATP +
ubiquitin + protein lysine
= AMP + diphosphate +
protein N-ubiquityllysine
0.32
SMALL_PROTEIN_CONJUGATING_ ENZYME_ACTIVITY GO:0008639. Catalysis of
the covalent attachment of
small proteins, such as
ubiquitin or ubiquitin-like
proteins, to lysine residues
on a target protein. This
function may be
performed alone or in
conjunction with an E3,
ubiquitin-like protein ligase
0.21
CASPASEPATHWAY BIOCARTA: Caspases are
cysteine proteases active in
apoptosis
0.30
* identified by GSEA (gene set enrichment analysis), using the databases MSigDB C2 and C5; number of entries is limited to gene sets with a false discovery rate
(FDR) < 0.35 in at least one of the treatments and FDR < 0.1 for the WC-Co 3 d treatment; only gene sets obviously related to biochemical pathways or cellular
organelles were selected; full table provided as Additional File 3
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sized dimensions or whether the same type of effects as
known for corresponding bulk material or dissolved
compounds occurs.
In the present paper we focussed on WC and WC-Co
nanoparticles which are used in hard metal industries.
Dermal uptake, inhalation or accidental oral uptake pre-
sent possible routes for occupational exposure for these
particles. Our previous study has demonstrated their
incorporation into various types of cells. Toxicity was
low but enhanced for WC-Co compared to pure WC
particles [21,22]. A transcriptome analysis of human
macrophages exposed to μm-sized WC-Co revealed dif-
ferential expression of genes known to be affected by
cobalt as well [33], providing first evidence that dis-
solved cobalt seems to play a role in WC-Co toxicity.
However, no direct comparison of transcription patterns
provoked by nano-sized WC-Co, WC and dissolved
cobalt is available so far. In order to model human skin
exposure, the human keratinocyte cell line (HaCaT) was
selected as experimental model to perform microarray
analyses. A number of statistical methods and database
analysis tools were used to compare the data sets and
perform a detailed pathway analysis.
Transcriptional changes in WC exposed cells
Identification of significantly altered genes revealed only
little changes for the exposure of HaCaT cells to WC.
Similar observations were made for WC in larger particle
size in vitro and in vivo [16,19]. The weak transcriptomic
response may be explained by the physicochemical charac-
teristics, since WC nanoparticles were shown to be chemi-
cally inert [21]. The genes detected as differentially
expressed with WC were mostly also affected by WC-Co
and CoCl2 ( e . g .E G L N 3 ,C A 9 ,B N I P 3 ,L O X L 2 ,P D K 1 ,
KRT1, MMP1). This might be due to traces of cobalt and
other metals in WC nanoparticle preparations that have
been reported at low concentrations of about 5 × 10
-4 μM
(described by Bastian et al., 2009 [21]). Some of the genes,
however, showed a reciprocal differential expression pat-
tern. For example, while induced by CoCl2,ar e p r e s s i o n
was detected for WC and WC-Co nanoparticles, for e.g.
T T L L 7 ,K I T ,C H S T 6 ,N O D A L ,W D R 6 4 ,D E S ,H S 6 S T 3 ,
DLX2, GPR158. In order to identify potential effects asso-
ciated with the dimensions of nanoparticles but not related
to the chemical compound, we compared our expression
data set with 503 genes that were found to be affected by
exposure to amorphous silica nanoparticles [12]. In this
study, transcriptomic profile of macrophages exposed to
amorphous silica particles in two different sizes and differ-
ent concentrations were recorded. Similar to WC, amor-
phous silica is known to be chemically inert. Only 29 out
of 503 of the silica-sensitive genes were also found to be
differentially expressed in our study. Since these genes
showed an altered expression with CoCl2 rather than with
WC particles, they may reflect a general unspecific stress
response.
Transcriptional changes in WC-Co and CoCl2 exposed
cells
Compared to the effects with WC nanoparticles, more
genes were affected by the WC-Co nanoparticles. Most
of them were altered by CoCl2 as well. We found strong
overlaps of the expression data of WC-Co and CoCl2
treated cells, whereas the highest number of genes dif-
ferentially expressed was found with CoCl2.A sd e m o n -
strated by GSEA analysis, the differentially expressed
genes involved in the transcriptional response to WC-
Co and CoCl2 could be associated to various biological
functions or signalling pathways which are discussed in
detail in the following paragraphs.
Whereas most of the affected genes were induced, a
number of genes repressed by WC, WC-Co and CoCl2
exposure have been found as well (e.g. MAL, OLFM4,
KRT1, CLCA2, MMP1, IQGAP2). For most of these
genes the mechanisms of transcriptional regulation are
not known and special pathways related to this group of
genes could not be identified.
The role of HIF1 for differential gene expression in WC-Co
and CoCl2 treated cells
Comparison of the pattern of significant genes and gene
set enrichment analyses demonstrated similar responses
and signalling pathways for cells exposed to WC-Co and
CoCl2, e.g. genes involved in the metabolism of glycoly-
sis and gluconeogenesis, cell adhesion and the response
to hypoxia. Under hypoxic conditions, the a subunit of
hypoxia inducible factor 1 (HIF1a) accumulates and
induces transcription of diverse target genes. HIF1a is a
transcription factor that is ubiquitously expressed but
rapidly degraded under normoxic conditions. Cobalt
ions are known to stabilise HIF1a under normoxic con-
ditions and therefore exert hypoxia-like cellular
responses [24-26,37]. Several genes sorted into gene sets
related to hypoxia and other pathways e.g. glycolysis and
gluconeogenesis, are primary targets of the transcription
factor HIF1. To analyse whether such HIF1 target genes
were affected by our treatments we generated a list of
HIF1target genes (list contained two gene sets from the
GSEA C3 TFT database and the “HIF1_Targets” gene
set (C2) that was generated after Semenza (2001) [28]).
When the expression of HIF1 primary targets is com-
pared, WC-Co nanoparticles provoke almost the same
pattern of induction or repression as CoCl2 (Figure 3).
HIF1 as an initial factor for downstream regulation
The list of affected HIF1 targets contained transcription
factors that could be involved in the regulation of sec-
ondary HIF1 targets. One example is SOX2. SOX2 con-
tains a putative HIF1 promotor binding site and was
found to be strongly repressed after 3 d of exposure
with WC-Co and CoCl2. SOX2 is known to play a key
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Greber et al. (2007) [41] studied the transcription profile
of embryonic stem cells and embryonic carcinoma cells
following a knock down of SOX2. In HaCaT cells
exposed to CoCl2, 97 genes with differential expression
(26 repressed, 71 induced genes) showed a similar
expression pattern if compared to the SOX2 knock
down. None of these genes is known as direct HIF1 tar-
gets or exhibit HIF1 binding sites and quite a few of
them were mentioned in the context of hypoxia earlier.
These genes might be regulated by the SOX2 transcrip-
tion factor as potential secondary HIF1 targets.
Endothelin 2 (EDN2) is another example for a gene
with a putative promoter HIF1 binding site that could
be involved in the differential expression of genes in the
CoCl2 treatment. In agreement with the HIF1 promotor
binding site, Na et al. (2008) [42] reported the induction
of EDN2 after 3 and 6 hours of hypoxic treatment in
granulosa cells. Similarly, EDN2 was found to be
induced in HaCaT cells exposed to WC-Co and CoCl2
after 3 h. An induction of other genes of the endothelin
complex (EDNRB, EDNRA, ECE2) was detected with
the same treatments after 3 d. The induction of collagen
mRNA levels and the repression of the matrix metallo-
peptidase 1 (MMP1) by the endothelin complex was
described by Shi-Wen and colleagues [43]. Indeed, an
induction of the collagen gene COL5A1 and the repres-
sion of the endothelin downstream target MMP1 were
detected in HaCaT cells exposed to WC-Co and CoCl2
for 3 d.
In addition to the sets of genes regulated by HIF1,
GSEA identified sets of genes that are regulated by
other transcription factors. However, similar to HIF1,
transcripts of the genes encoding the transcription fac-
tors themselves were not found to be differentially
expressed. The list (see Additional file 3) contained
transcription factors known to be HIF1a interaction
partners - e.g. ARNT (aryl hydrocarbon nuclear translo-
cator, [44]) - or HIF1 supporting factors - e.g. (AP1,
[45]; Smad3/4; [46]), but also a number of the enriched
gene sets not known to be related to HIF1 or targets of
HIF1 (such as BACH2, NEF2, ALX4, PAX3).
By comparing HIF1 target genes with known hypoxia
responsive genes it becomes obvious that only part of
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Figure 3 Expression of HIF1a target genes. HIF1a target genes and their expression levels after 3 d of exposure of HaCaT cells to 30 μg/ml
WC and 33 μg/ml WC-Co nanoparticles and 3 μg/ml CoCl2. Bars indicate the mean microarray expression levels of 5 biological replicates. This
figure represents all affected HIF target genes identified as significantly differentially expressed by SAM without a fold change threshold.
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indirect targets of HIF1. Nevertheless, the fact that most
of the genes and pathways affected with WC-Co and
CoCl2 were also observed in toxicogenomic studies
investigating hypoxia [8,47,48] led us to conclude that
the stabilisation of HIF1a via cobalt is an initial step
and most of the reactions that are not directly related to
HIF1a might reflect downstream events.
Cobalt ions as co-factor substitute
In CoCl2 treated cells the YY1 transcription factor was
identified as a potential master regulating factor with
GSEA. YY1 is a ubiquitous transcription factor with fun-
damental biological functions. Its role in cancer biology
is also intensely discussed [49]. An interaction of YY1
with cobalt was not yet described but might be concei-
vable, because YY1 contains four zinc finger domains.
The substitution of zinc ions and other divalent metal
ions by Co
2+ i so f t e nd i s c u s s e dt op l a yar o l ei nt r a n -
scription factor domains, DNA repair mechanisms and
calcium metabolism [50-52]. The transcriptional changes
of YY1 target genes after the CoCl2 exposure indicate an
induction or enrichment of the YY1 protein but it
remains unclear, whether the substitution of zinc ions
by Co
2+ is responsible for that.
In HaCaT cells, a significant depletion of intracellular
Zn
2+ and Mg
2+ after CoCl2 exposure was described by
Ortega and colleagues [53]. A substitution of magnesia
ions by Co
2+ may result in the interruption of ATPases
and the energy balance of the cell [54]. It is proposed
that ion substitution plays a role in uptake mechanisms
of cobalt ions into cells, which evidently happens via
cation-dependent ionic pumps [50,53]. Although we
found gene sets related to metal ion or cation ion bind-
ing proteins to be affected, we did not detect an enrich-
ment of gene sets connected to the described effects
resulting from ion substitution.
Differential expression of protein kinases and
phosphatases
It was noticed that in WC-Co and CoCl2 exposures sev-
eral kinases and phosphatases exhibited a differential
expression. Kinases are a major group of proteins
involved in endocytosis [55,56]. In a knock-down study
of Pelkmans and colleagues (2005) [56] 209 kinases with
known important functions in several pathways were
identified to be involved in endocytosis. Interestingly,
most of the pathways they could link with endocytotic
processes were also affected in our study (e.g. mTOR,
Wnt, integrin/adhesion, RTKs/RSTKs, GPCR).
Protein tyrosine phosphatases (PTPs) and kinases as well
as enzymes of the phosphoinositol-3-kinase family (PI3Ks)
seem to play a special role in the response to cobalt. The
latter have been described as possible upstream regulators
of HIF1a [57-60] and have functions in some of the path-
ways found to be induced (e.g. Insulin-, IGF1-, PPARa-
pathway; based on GSEA analysis). PTPs are known to be
signalling molecules that regulate a variety of cellular pro-
cesses including cell growth, differentiation, mitotic cycle,
and oncogenic transformation. Some genes coding for
PTPs were not only affected by the cobalt containing
treatments but also by WC (PPFIA4, PTPRT, PTPRZ1).
Since kinases and phosphatases are also involved in the
cellular response to various kinds of environmental stress,
their altered expression may be related to a cobalt-induced
and/or a particle uptake related stress response.
Oxidative stress and transcriptional response
The production of reactive oxygen species (ROS) and
the subsequent induction of oxidative stress are dis-
cussed as major modes of action of nanoparticles
[2,61,62] and was also described to be involved in the
cellular response to cobalt ions [54,63,64]. Nevertheless,
genes or gene clusters that are related to oxidative stress
responses could not be found within our data set of dif-
ferentially expressed genes. This was confirmed by a
lack of ROS production in HaCaT cells for any of the
treatments (manuscript in preparation).
Cobalt ions and WC-Co toxicity
Cobalt is an essential trace element for humans, but
becomes toxic at high concentrations. In a previous
study, we analysed acute toxicity by measuring cell viabi-
lity of HaCaT cells after same exposure conditions as
performed in this study [21]. Altered proliferation or
morphological changes of the cells were not observed.
Toxicity of CoCl2 was indicated by decreasing cell viabi-
lity at concentration of 100 μM( c o r r e s p o n d st o6μg/ml)
and above. Lower concentrations of CoCl2 have not been
observed to cause acute toxicological reactions in several
cells in vitro, including in HaCaT cells [21,54,65]. Intense
transcriptional changes were observed in this study at
concentrations slightly below those causing in vitro toxi-
city. The differentially expressed genes may serve as indi-
cators for potential long term effects and may also be
useful for investigations of molecular mechanisms.
WC-Co nanoparticles exhibited an increased toxicity in
previous studies performed in different types of cell lines
(human and fish) when compared to WC particles and
CoCl2 [21,22]. Viability of HaCaT cells was slightly (15%)
decreased after 3 days of exposure. This enhanced toxi-
city was discussed as either a result of increased cellular
cobalt uptake associated with the uptake of WC particles
- the so called “Trojan horse” hypothesis [61] - or a result
of unknown combinatory effects of WC particles and
cobalt. The “trojan horse” theory is supported by studies
showing increased toxicity of nanoparticles with leaching
ions compared to the ions alone [11,66-68]. However,
analysing the global transcriptional response of HaCaT
cells to WC-Co nanoparticles and equivalent WC and
cobalt treatments, no evidence for either of these theories
could be provided. The number of transcriptional
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but particularly the regulation of genes resulting from
cobalt dependent stabilisation of HIF1a was similar for
both, WC-Co and CoCl2. The patterns of transcriptional
regulation clearly indicate that the majority of the effects
were associated with cobalt ions and did not indicate a
special type of interaction between WC and cobalt. How-
ever, the enhanced toxicity of WC-Co with respect to
CoCl2 appears to be mediated via unknown non-tran-
scriptionally regulated pathways.
Conclusion
Analysis of gene expression patterns in the human kera-
tinocyte cell line HaCaT demonstrated that the tran-
scriptional response to WC-Co nanoparticles is mainly
caused by cobalt ions leaching from the particles. While
WC nanoparticles alone do only show very weak effects
in expression patterns, WC-Co and CoCl2 exhibited sig-
nificant transcriptional changes in genes involved in car-
bohydrate metabolism, hypoxia response, endocrine
pathways, cell adhesion and others. The cobalt-sensitive
transcription factor HIF1 plays an important role in the
regulation of genes involved in these pathways, showing
that WC-Co nanoparticles exert hypoxia-like responses
similar to CoCl2. The subacute response to CoCl2 was
analysed and discussed with respect to downstream
events of HIF1 and involvement of other transcription
factors (e.g. SOX2, YY1) in cobalt toxicity. A simplified
scheme of potential major pathways resulting from
cobalt reactions within the cell is provided in Figure 4.
However, while detailed analyses of transcriptional
regulations clearly indicate that leached cobalt is likely
to be the major trigger for gene regulation in cells
exposed to WC-Co, the changes in transcription pat-
terns do not explain the enhanced toxicity of WC-Co if
compared to equivalent concentrations of WC or CoCl2.
This enhanced toxicity is suggested to be mediated by
unknown combinatory effects of WC and cobalt not
reflected primarily at the transcriptional response level.
However, support or rejection of this hypothesis
requires further investigations.
Methods
Preparation and characterisation of particle suspensions
and cobalt chloride solutions
Particles and exposure conditions used in this study
were identical to those in a previous study which also
describes details of the particle preparation, characteri-
sation and behaviour in cell culture media [21]. Briefly,
particle suspensions with a concentration of 100 μg/ml
were prepared from tungsten carbide (WC) and tung-
sten carbide cobalt (WC-Co; 10 mass % cobalt content)
powders as described in detail by Bastian et al. [21]. Par-
ticles exhibited a Brunauer-Emmett-Teller (BET) specific
surface area of 6.9 m
2/g (WC) and 6.6 m
2/g (WC-Co). A
mean particle size 56 and 62 nm was calculated from
BET values (dBET) for WC and WC-Co, respectively. By
dynamic light scattering a mean particle size of 145 ± 5
nm for both WC and WC-Co was estimated (calculated
according to DIN ISO 13321 [69]). Similar ranges of
particle size distribution and morphology were mea-
sured for both types of particles. Particle size was shown
to be stable in cell culture media supplemented with
FBS (see also [21]). One week after the preparation of
the suspension about 6% of tungsten from WC and 15%
of tungsten and 76% of cobalt from WC-Co were found
to be dissolved [21].
Exposure of cells to nanoparticles was performed
using stock suspensions of 300 μg/ml WC (in water)
and 330 μg/ml WC-Co (consisting of 300 μg/ml WC
and 30 μg/ml cobalt, in 0.03% sodium polyphosphate,
see Bastian et al. [21]). Particle suspensions were steri-
lised by autoclaving and treated for 10 min with ultra-
sound (Merck Eurolab, Darmstadt, Germany) to
disperse aggregates before exposure of cells. Previous
investigations did not reveal any changes in particle
characteristics by autoclaving and re-dispersing [21].
A cobalt chloride (Fluka/Sigma-Aldrich, Seelze, Ger-
many) stock solution of 10 mM was prepared in distilled
water, sterilised by autoclaving and diluted with cell cul-
ture grade water (PAA Laboratories, Pasching, Austria).
All suspensions and solutions were kept at 4°C.
HaCaT cell culture and exposure of cells
The permanent human keratinocyte cell line, HaCaT
(purchased from CLS - Cell Lines Service, Eppelheim,
Germany) [70], was maintained in RPMI medium (’Ros-
well Park Memorial Institute’ medium; Biochrom, Karls-
ruhe, Germany) supplemented with 5% (v/v) FBS and
1% (v/v) penicillin/streptomycin. Cells were cultured in
monolayers at 37°C in a humidified, 5% (v/v) CO2-atmo-
sphere and sub-cultured twice a week in 75 cm
2 flasks
(Techno Plastic Products AG, Trasadingen, Switzerland);
passages 30 to 40 were used for experiments. For sub-
culturing, cells were washed three times with Versene
(Invitrogen/Gibco, Berlin, Germany) and detached by
trypsin (0.25% (v/v) in phosphate-buffered saline (Bio-
west, Renningen, Germany).
Cells were counted using a haemocytometer and
seeded at densities of 2 × 10
5 cells/ml for 3 d of expo-
sure or 5 × 10
5 cells/ml for 3 h of exposure, respectively
in a final volume of 10 ml per 75 cm
2 flasks. In order to
synchronise proliferation prior to exposure with nano-
particles, cells were allowed to grow for 24 h in RPMI
with 5% FBS and subsequently for 24 h in RPMI with-
out FBS for synchronisation [71]. Subsequently, cells
were exposed to 30 μg/ml WC, 33 μg/ml WC-Co
(cobalt content was 3 μg/ml), or 3 μg/ml cobalt chloride
by mixing RPMI containing 5% FBS with 10 fold
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in the dark with 5 independent replicates (performed at
different days using different cell passage numbers).
Controls were performed with the water used for the
preparation of particle suspensions. The WC-Co suspen-
sion also contained polyphosphate (0.003% v/v). How-
ever, polyphosphate was not included in controls since
the final polyphosphate concentration did not exceed
the normal sodium phosphate concentration in cell cul-
ture media. Furthermore, no evidences for any effect of
low polyphosphate concentrations on cell vitality and
function was observed in a previous study [21]. As also
shown previously [21], nanoparticles did not aggregate
during the exposure period if exposure was performed
in FBS supplemented cell culture medium.
RNA extraction
Total RNA was extracted from 75 cm
2 cell culture flasks
with 1 ml Trizol reagent (Invitrogen, Karlsruhe, Ger-
many) according to the manufacturer’s instructions. RNA
samples were additionally purified using the RNeasy Kit
(Qiagen, Hilden, Germany), RNA qualities and quantities
were determined with the Experion detection system
(Biorad, Munich, Germany).
Microarray experiments
The effect of the different treatments on transcription
profiles of HaCaT cells was compared by microarray
analysis (whole genome human 44K array, Agilent Tech-
nologies, Böblingen, Germany). Therefore, microarray
hybridisations were performed for each treatment (con-
trol, WC 30 μg/ml, WC-Co 33 μg/ml, CoCl2 3 μg/ml; 3
h and 3 d exposure each) with 5 independent biological
replicates. All hybridisations were performed against a
common reference RNA [72] consisting of a mixture of
equal amounts of RNA from all treatments. Synthesis of
cDNA, cRNA and cRNA-labeling was performed with
the Agilent Low RNA Input Linear Amplification Kit
according to the manufacturer’s instructions. cRNA was
labelled with Cy3 (controls and treatments) and Cy5
(common reference). Cy3 and Cy5 labelled cRNA were
combined and hybridised to the microarray slides in the
DNA Microarrays Hybridisation Oven (Agilent Technol-
ogies). Slides were scanned with the Agilent DNA
Figure 4 Scheme of affected cellular pathways. Illustration of the major cellular signalling pathways that were indicated by analyses of the
transcriptional responses to WC-Co nanoparticles and cobalt chloride. Arrows indicate known (full lines) or potential (dashed lines) interactions.
(Complex Proteins = orange, Transcription Factors = green).
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tion and scanning were performed according to standard
protocols of the manufacturer.
Microarray data analysis
Dye-normalised fluorescent intensities of individual
microarray spots were extracted using the Agilent Fea-
ture Extraction software 9.5. Data were further normal-
ised by dividing the Cy3/Cy5 ratio of each treatment by
the mean Cy3/Cy5 ratio of the controls. Data were then
analysed using the TMEV software version 4.3 (http://
www.tm4.org/) [73]. Genes with significantly altered
expression patterns were identified by a modified t-statis-
tic (SAM = significance analysis of microarrays) [74].
Multiple comparison of the complete data set was per-
formed using the lowest possible false discovery rate that
allows identification of significantly differentially
expressed gene (FDR < 0.03%). Further descriptive analy-
sis by hierarchical clustering (TMEV 4.3) and principal
component analysis (PCA, JMP 8.0, SAS institute; http://
www.jmp.com) was restricted to the statistically signifi-
cant genes. Fold changes (FC) of expression levels were
calculated using the mean values of each treatment and
the mean of the respective controls. A complete list of
FC-values of all significantly differentially expressed
genes is included in the supplementary information sec-
tion of this paper (Additional file 1). The microarray data
have been submitted to the Gene Expression Omnibus
(GEO) database (series no. GSE16727, http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE16727).
Gene set enrichment and pathway analysis
In order to identify biological pathways and functions
associated with the changes in gene expression patterns,
transcription profiles were analysed by Gene Set Enrich-
ment Analysis (GSEA) [34,35](http://www.broad.mit.
edu/gsea/). GSEA is based on ranking of the genes
according to their statistical significance and comparison
of the patterns to sets of predefined genes. These
predefined gene sets are provided by the Molecular Sig-
natures Database (MSigDB) and include five different
types of databases (C1 to C5). For our analyses we used
the databases C2 (gene sets collected from various
sources such as online pathway databases, publications
in PubMed including microarray studies, and knowledge
of domain experts), C3 (transcription factor targets, i.e.
genes that share a transcription factor binding site
defined in the TRANSFAC database version 7.4, http://
www.gene-regulation.com/) and C5 (gene sets of the
Gene Ontology (GO) database, http://www.geneontol-
ogy.org). Further details are explained on the MSigDB
homepage http://www.broad.mit.edu/gsea/msigdb/index.
jsp. Since GSEA does not allow the analysis of multiple
datasets, analysis was performed pair wise comparing
each treatment with the control.
Furthermore, pathway analysis was performed by
means of the Database for Annotation, Visualisation and
Integrated Discovery (DAVID) [36] (http://david.abcc.
ncifcrf.gov/)using the list of differentially expressed
genes identified by SAM (see above).
RT-PCR
cDNA was synthesised from RNA using the RevAid™
First Strand cDNA Synthesis Kit (MBI Fermentas, St.
Leon-Rot, Germany) according to the manufacturer’s
instructions. Primers were designed using the computer
program Primer3 [75] or Beacon Designer 7 (Premier
Biosoft, Palo Alto, USA; (http://www.PremierBiosoft.
com) and purchased from Invitrogen. Primer sequences
are listed in Table 4.
Target genes and the reference gene RPL41 [76] were
amplified from 1 μl of cDNA using 1 unit of Taq Poly-
merase (Promega, Mannheim, Germany), 50 mM TRIS-
HCl (pH 9.0, Serva, Heidelberg, Germany), 1.5 mM
MgCl2 (Sigma, Steinheim, Germany), 15 mM (NH4)2SO4
(Sigma), 0.1% (v/v) Triton-X 100 (Merck, Darmstadt,
Germany), 0.2 mM dNTPs (MBI Fermentas) and 0.6
Table 4 Sequences of primers used for the validation of microarray data by RT-PCR
Gene Name GenBank Accession Forward Primer Sequence Reverse Primer Sequence
RPL41 NM_021104 AAGATGAGGCAGAGGTCCAA TCCAGAATGTCACAGGTCCA
LOXL2 NM_002318 AGCTTCTGCTTGGAGGACACA TGAAGGAACCACCTATGTGGCA
ANGPTL4 NM_139314 GTCCTCGCACCTGGAACCC CTTCGGGCAGGCTTGGCCAC
PFKFB4 NM_004567 TCCCCACGGGAATTGACAC GAGAGTTGGGCAGTTGGTCAT
BNIP3 NM_004052 ACACCACAAGATACCAACAGG TCTTCATGACGCTCGTGTTCCTC
GAPDH NM_002046 AGGCTGAGAACGGGAAGC AGAGGGGGCAGAGATGATG
CA9 NM_001216 AACCAGACAGTGATGCTGAGT TGGCATAATGAGCAGGACAGGA
MAL NM_002371 AAACATTGCTGCCGTGGTGTTC AGGTTAGACACAGCAAGCTCCCA
OLFM4 NM_006418 ATTGGGTGGCGCCATTGAATA TGGTGTTCATAGTACGGGTGGCA
ID2 NM_002166 GACCCGATGAGCCTGCTATAC AATAGTGGGATGCGAGTCCAG
DSG4 NM_177986 TGAAGATGAAGGTCGACCAGC GGGTTGCACACATGGATCAGCAT
KRT1 NM_006121 AGAATGCCCTCAAGGATGCCA TTCTCCGGTAAGGCTGGGACAAA
MMP1 NM_002421 AAGAGGCTGGGAAGCCATCAC TCAGTGAGGACAAACTGAGCCA
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number of cycles was adjusted to obtain amplified DNA
during the exponential phase of the reaction. Annealing
was performed at 55°C. PCR-fragments were analysed
by agarose gel electrophoresis (1.5% w/v agarose) and
ethidium bromide staining (0.005% w/v). mRNA abun-
dance was evaluated by either visual comparison of
band intensity or densitometric analysis using the image
analysis software ImageJ (Version 1.33u, available at
http://rsb.info.nih.gov/ij/). Relative gene expression
levels were calculated by normalisation of band intensi-
ties to the reference gene. These relative gene expres-
sion values were converted to percent of the average
control values. Statistical differences were analysed after
confirmation of normal distribution (Kolmogorov-Smir-
nov test) with one-way ANOVA followed by Dunnett’s
post test using GraphPad Prism 4.0 software (GraphPad
Software, San Diego California USA, http://www.graph-
pad.com). Values of p < 0.05 were considered statisti-
cally significant.
Additional file 1: Table contains all significantly altered expressed
genes and fold changes for all treatments
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
65-S1.XLS]
Additional file 2: Heat map of differentially expressed genes and
hierarchical clustering of all replicates
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
65-S2.PDF]
Additional file 3: Table contains all gene sets and pathways identified
as enriched by GSEA and DAVID
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
65-S3.XLS]
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